Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 2 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Jazz Pharmaceuticals Ireland Limited currently faces 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 5 actions are distributed among 5 distinct examiners, ensuring that no single examiner is managing more than one pending case for the company at this time. Prosecution is occurring across 2 distinct art units, which concentrates the 5 pending matters into a limited number of specialized groups.
BAUER, BRIANNA LEE is the busiest examiner for the portfolio, holding 1 pending office action. This figure matches the workload of the other distinct examiners involved in the company's pending office actions. The presence of 5 examiners across only 2 art units suggests that multiple examiners within the same specialized units are reviewing the company's pharmaceutical applications. This high ratio of examiners to art units can lead to varied perspectives on similar technical subject matter, requiring a coordinated approach to prosecution. Practitioners should be prepared to navigate different examiner styles while maintaining consistency across the two primary art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §112 only | 2 (33%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OTTON, ALICIA L | 1 | 64.9% | +9.4% |
| BAUER, BRIANNA LEE | 1 | 100.0% | +0.0% |
| WEDDINGTON, KEVIN E | 1 | 75.2% | +9.8% |
| SEAMAN, D MARGARET M | 1 | 76.5% | +8.0% |
| BELL, SARA ELIZABETH | 1 | 68.8% | +38.2% |
| REDWOOD, CHRISTOPHER EVAN | 1 | 0.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18849340 | TRICYCLIC PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORS | BAUER, BRIANNA LEE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18353770 | BIARYL ETHER UREA COMPOUNDS | REDWOOD, CHRISTOPHER EVAN | 89d overdue |
| 18727926 | NOVEL AMINE-SUBSTITUTED PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORS | SEAMAN, D MARGARET M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294129 | METHOD OF TREATING POSTTRAUMATIC STRESS DISORDER | BELL, SARA ELIZABETH | 21d |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18869941 | MACROCYCLIC OREXIN RECEPTOR AGONISTS AND USES THEREOF | OTTON, ALICIA L | — | §112 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18849340 | TRICYCLIC PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORS | BAUER, BRIANNA LEE | — | §112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18727976 | METHOD OF ADMINISTERING OXYBATE | WEDDINGTON, KEVIN E | — | DPOther | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18727926 | NOVEL AMINE-SUBSTITUTED PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORS | SEAMAN, D MARGARET M | — | §102§103§112 | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18294129 | METHOD OF TREATING POSTTRAUMATIC STRESS DISORDER | BELL, SARA ELIZABETH | 1625 | §103 | Non-Final OA | 21d | Pending | Jan 31, 2024 |
| 18353770 | BIARYL ETHER UREA COMPOUNDS | REDWOOD, CHRISTOPHER EVAN | 1629 | §103Other | Final Rejection | 89d overdue | Pending | Jul 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial